Malina Giselle E K, Heiferman Daniel M, Riedy Loren N, Szujewski Caroline C, Rezaii Elhaum G, Leonetti John P, Anderson Douglas E
Departments of1Neurological Surgery and.
3Department of Neurobiology, University of Chicago, Illinois.
J Neurosurg Pediatr. 2020 May 29;26(3):302-310. doi: 10.3171/2020.3.PEDS19514. Print 2020 Sep 1.
Sporadic unilateral vestibular schwannomas are rare in the pediatric population. Little has been reported in the literature on the presentation, tumor size, response to surgical treatment, and recurrence rates in these younger patients. The authors' goal was to describe their institutional experience with pediatric sporadic vestibular schwannomas and to conduct a meta-analysis of the existing literature to provide further insight into the presentation, tumor characteristics, and surgical outcomes for these rare tumors to help direct future treatment strategies.
The authors performed a retrospective review of all patients 21 years of age or younger with unilateral vestibular schwannomas and without neurofibromatosis type 2 who underwent resection by the senior authors between 1997 and 2019. A systematic review of the literature and meta-analysis was also performed by entering the search terms "pediatric" and "vestibular schwannoma" or "acoustic neuroma," as well as "sporadic" into PubMed. Presentation, treatment, clinical outcomes, and follow-up were analyzed.
Fifteen patients were identified at the authors' institution, ranging in age from 12 to 21 years (mean 16.5 years). Common presenting symptoms included hearing loss (87%), headache (40%), vertigo (33%), ataxia (33%), and tinnitus (33%). At the time of surgery, the mean tumor size was 3.4 cm, with four 1-cm tumors. Four patients had residual tumor following their first surgery, 3 (75%) of whom had significant radiographic regrowth that required further treatment. The literature review identified an additional 81 patients from 26 studies with patient-specific clinical data available for analysis. This resulted in a total of 96 reported patients with an overall average age at diagnosis of 12.1 years (range 6-21 years) and an average tumor size of 4.1 cm.
Pediatric vestibular schwannomas present similarly to those in adults, although symptoms of mass effect are more common, as these tumors tend to be larger at diagnosis. Some children are found to have small tumors and can be successfully treated surgically. Residual tumors in pediatric patients were found to have a higher rate of regrowth than those in their adult counterparts.
散发性单侧前庭神经鞘瘤在儿科人群中较为罕见。关于这些较年轻患者的临床表现、肿瘤大小、手术治疗反应及复发率,文献报道较少。作者的目标是描述其机构治疗儿童散发性前庭神经鞘瘤的经验,并对现有文献进行荟萃分析,以进一步深入了解这些罕见肿瘤的临床表现、肿瘤特征及手术结果,从而为未来的治疗策略提供指导。
作者对1997年至2019年间由资深作者进行手术切除的所有21岁及以下单侧前庭神经鞘瘤且无2型神经纤维瘤病的患者进行了回顾性研究。还通过在PubMed中输入搜索词“儿科”和“前庭神经鞘瘤”或“听神经瘤”以及“散发性”,对文献进行了系统回顾和荟萃分析。分析了临床表现、治疗、临床结果及随访情况。
作者所在机构共确定了15例患者,年龄在12至21岁之间(平均16.5岁)。常见的临床表现包括听力丧失(87%)、头痛(40%)、眩晕(33%)、共济失调(33%)和耳鸣(33%)。手术时,平均肿瘤大小为3.4 cm,有4个1 cm大小的肿瘤。4例患者首次手术后有残留肿瘤,其中3例(75%)有明显的影像学复发,需要进一步治疗。文献回顾从26项研究中又确定了81例患者,这些患者有可供分析的特定临床数据。这使得总共报告了96例患者,诊断时的总体平均年龄为12.1岁(范围6至21岁),平均肿瘤大小为4.1 cm。
儿童前庭神经鞘瘤的表现与成人相似,尽管占位效应的症状更常见,因为这些肿瘤在诊断时往往更大。一些儿童的肿瘤较小,可通过手术成功治疗。发现儿科患者残留肿瘤的复发率高于成人患者。